Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | bg5j4 | RA |
Patient received second Arexvy injection against guideline recommendations. described no adverse reactions. patient self-reported as a nurse
none
none
none
nkda